← Evidence map

ArticleMolecular pharmaceutics2013

A chimeric p53 evades mutant p53 transdominant inhibition in cancer cells.

Abood Okal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

14 papers cite it

2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 23964676